Continuous Regional Analysis Device for Neonate Lung

NCT ID: NCT02962505

Last Updated: 2019-03-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-11-30

Study Completion Date

2019-03-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to assess whether Electrical Impedance Tomography (EIT) has the potential to optimize the ventilator therapy, validate the effectiveness, efficacy and safety of nursing and medical interventions (endotracheal suctioning, posture changes, surfactant therapy, recruitment manoeuvres, etc.) and for early recognition of complications like pneumothorax and endotracheal tube misplacement. The study design is purely observational.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

EIT data will be recorded during 72 hours of routine clinical treatment. To prevent any decisions based on EIT information, the clinicians will be blinded to the EIT findings during the study period. Data on clinical interventions and clinical findings will be recorded using a specially adapted graphical user interface on the EIT device in combination with a paper-based case report form (CRF). EIT data analysis will be performed off-line.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infant Respiratory Distress Syndrome Acute Bronchiolitis Acute Respiratory Distress Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Written, informed consent of both parents or legal representative
* Admission in the NICU or PICU
* Patients with or at high risk of developing respiratory failure needing respiratory support.

o i.e. (oxygen need (FiO2\>25%) AND noninvasive or invasive respiratory support) AND/OR repeated apnea with desaturations
* Age from birth to 7 years o Initial focus will be on neonates up to 6 kg and 12 months age. Infants of higher weight up to 7 years age will be included as EIT belts for this age group become available.

Exclusion Criteria

* Post menstrual age less than 25 weeks
* Body weight \< 600 g
* Electrically active implants
* Thorax skin lesions
* Prior participation for the same diagnosis of lung disease
Maximum Eligible Age

7 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Middlesex University London

UNKNOWN

Sponsor Role collaborator

University College, London

OTHER

Sponsor Role collaborator

NICU of Makarios III Hospital-The Ministry of Health for the Republic of Cyprus

UNKNOWN

Sponsor Role collaborator

Bio-Medical Research Foundation

UNKNOWN

Sponsor Role collaborator

University of Geneva

UNKNOWN

Sponsor Role collaborator

Linneuniversitetet

UNKNOWN

Sponsor Role collaborator

SWISSTOM AG

UNKNOWN

Sponsor Role collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

Sponsor Role collaborator

Studio Fifield

UNKNOWN

Sponsor Role collaborator

Panaxea

OTHER

Sponsor Role collaborator

University Hospital Schleswig-Holstein

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Inez Frerichs

Prof. Dr. Inéz Frerichs

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Inez Frerichs, MD

Role: STUDY_CHAIR

University Medical Center SH, Kiel , Germany

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Archbishop Makarios III Hospital

Nicosia, , Cyprus

Site Status

Oulu University Hospital

Oulu, , Finland

Site Status

Academic Medical Center

Amsterdam, , Netherlands

Site Status

VU University Medical Center

Amsterdam, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Cyprus Finland Netherlands

References

Explore related publications, articles, or registry entries linked to this study.

Becher TH, Miedema M, Kallio M, Papadouri T, Karaoli C, Sophocleous L, Rahtu M, van Leuteren RW, Waldmann AD, Strodthoff C, Yerworth R, Dupre A, Benissa MR, Nordebo S, Khodadad D, Bayford R, Vliegenthart R, Rimensberger PC, van Kaam AH, Frerichs I. Prolonged Continuous Monitoring of Regional Lung Function in Infants with Respiratory Failure. Ann Am Thorac Soc. 2022 Jun;19(6):991-999. doi: 10.1513/AnnalsATS.202005-562OC.

Reference Type DERIVED
PMID: 34898392 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

668259

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Non-Invasive Respiratory Monitor
NCT02851043 RECRUITING NA